National impact of a constraining regulatory framework on pregabalin dispensations in France, 2020–2022
The constraining regulation adopted in 2021 by the French health authorities significantly curtailed total pregabalin dispensing in community pharmacies. Our findings underscore the importance of regulatory measures to limit the misuse of a prescribed medication.
Authors
- Benjamin Rolland (ORCID: https://orcid.org/0000-0002-8666-3635)
- Mathieu Chappuy (ORCID: https://orcid.org/0000-0002-3176-6039)
- Patrick M. Guérin (ORCID: https://orcid.org/0000-0002-2257-5097)
- Julia de Ternay (ORCID: https://orcid.org/0000-0003-4239-2113)
- Claire Meley
- Sébastien Meige
- Nicolas Grelaud (ORCID: https://orcid.org/0009-0004-9994-6900)
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Centre de Recherche en Neurosciences de Lyon (FR)
- Hospices Civils de Lyon (FR)
- Health Services and Performance Research Laboratory (FR)
- Centre Hospitalier Le Vinatier (FR)
- Research on healthcare performance (FR)
- Nantes Université (FR)
Publication Details
- Journal
- International Journal of Drug Policy
- Published
- 2024-11-23
- DOI
- https://doi.org/10.1016/j.drugpo.2024.104660
- Citations
- 5
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.71